SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,346,200 | -66.1% | 130,000 | -65.8% | 0.06% | -57.8% |
| Q4 2022 | $9,883,800 | +87.8% | 380,000 | +106.0% | 0.15% | +111.0% |
| Q3 2022 | $5,264,000 | +4642.3% | 184,500 | +4006.4% | 0.07% | +3550.0% |
| Q2 2022 | $111,000 | -98.8% | 4,493 | -97.3% | 0.00% | -98.2% |
| Q1 2022 | $9,323,000 | – | 165,180 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $125,662 | 14.04% |
| Finepoint Capital LP | 643,000 | $16,724 | 5.41% |
| Boxer Capital, LLC | 3,421,541 | $88,994,281 | 4.69% |
| Deep Track Capital, LP | 3,109,886 | $80,888,135 | 3.40% |
| Artal Group S.A. | 2,000,000 | $52,020 | 2.90% |
| EcoR1 Capital, LLC | 3,460,208 | $90,000,010 | 2.74% |
| M28 Capital Management LP | 109,900 | $2,858,499 | 2.72% |
| Orbimed Advisors | 5,250,000 | $136,552,500 | 2.61% |
| Perceptive Advisors | 2,617,691 | $68,086,143 | 1.91% |
| SPHERA FUNDS MANAGEMENT LTD. | 316,625 | $8,235,416 | 1.77% |